Silver Book

Silver Book Fact

The use of ACE inhibitors in hypertensive patients 80 years of older was associated in this study with a 30% reduction in the rate of stroke and a 64% reduction in the rate of heart failure. Additionally, these patients had 39% fewer fatal strokes, a 23% lower rate of cardiovascular events, and 21% fewer deaths from all causes.

Beckett N, Peters R, Fletcher A, Staessen J, et al. Treatment of Hypertension in Patients 80 Years of Age or Older. NEJM. 2008; 358(18): 1887-98. http://content.nejm.org/cgi/content/short/NEJMoa0801369

Reference

Title
Treatment of Hypertension in Patients 80 Years of Age or Older
Publication
NEJM
Publication Date
2008
Authors
Beckett N, Peters R, Fletcher A, Staessen J, et al
Volume & Issue
Volume 358, Issue 18
Pages
1887-98
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Savings associated with t-PA treatment for ischemic stroke patients
    A $600 net savings is associated with each ischemic stroke patient treated with t-PA. In 2005, only 2% of all ischemic stroke patients received t-PA. If that percentage was increased…  
  • Cost of warfarin therapy for AFib patients
    In patients with nonvalvular atrial fibrillation (AF) and one additional stroke risk factor, warfarin therapy cost $8,000 per quality-adjusted life-year (QALY) saved.  
  • t-PA cost savings
    The total annual benefit to society from t-PA use in the United States is around $363 million—$60 million in direct cost savings to society plus an additional 7,510 QALYs. This means…  
  • Satisfaction with HVD Treatment
    Among treated heart valve disease (HVD), 96% express “full satisfaction” and 78% are “very satisfied” with their treatment.  
  • The projected economic value of eliminating deaths from heart disease is approximately $48 trillion.